Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), most likely originated from zoonotic coronavirus in China, has caused coronavirus disease 2019 (COVID-19). Currently, COVID-19, a pandemic declared by World Health Organization (WHO) in March 2020, has spread widely across the world, affecting 215 countries and territories, leading to more than 21 million confirmed cases, and 762,000 deaths.

The virus is transmitted mainly via droplet infection and recently airborne infection has also been identified as a possible mode for transmission. The pathogenesis of COVID-19 seems to be highly complex and involve organs other than lungs and bronchial tree. Although the virus is not so cytopathic, it causes serious types of diseases by modulation the immune system of the infected persons.

The health care delivery systems of developed and advanced countries, especially the Group Seven (G7) countries, formulated different programs to contain the pandemic. However, almost all developed countries, including the United States of America (USA) failed to provide a viable program for containment of the virus even after spending trillions of dollars. UK initially took an aberrant path to contain the virus and finally altered it. Germany, France, and Italy also had high morbidity and mortality. Canada tried to control the pandemic, but it also embraced considerable mortality. Among G7 member countries, Japan contained the virus with minimum cases and minimum mortality by profound cooperation from its people and due to its unique health system for all of it’s citizen. The countries those are in between G7 countries and developing ones are also highly affected by COVID-19 pandemic with considerable morbidity and mortality.

Developing and resource-constrained countries are highly variable regarding their population, economic status, and nature of governance. All of them did their best to contain the pandemic. However, several long-lasting problems and realities as well as the fundamentals of health care delivery system of some developing and resource-constrained countries appeared to be counterproductive for containing this pandemic. Control of pandemic is a matter of comprehensive action of several branches of the government. Lack of coordination among curative and preventive health services, corruption in health-related establishments, presence of syndicate, incoherent and unrealistic policies, immoral physicians and health care personnel, inefficacy of health-related regulatory bodies and lack of scientific oversights are major factors influencing containment of the pandemic in some developing and resource-constrained countries. Elimination of these limitations are extremely necessary for facing COVID-19 pandemic and any future health emergencies of these countries.

Keywords: COVID-19 Pandemic; SARS-CoV-2; Developed Countries; Developing Countries; Health Syndicate

References

1. Otu A., et al. “Mental health and psychosocial well-being during the COVID-19 pandemic: the invisible elephant in the room”. International Journal of Mental Health Systems 14 (2020): 38. 
2. Zhu N., et al. “A novel coronavirus from patients with pneumonia in China, 2019”. The New England Journal of Medicine 382.8 (2020): 727‐733. 
3. WHO. Coronavirus disease (COVID-19) Situation Report (2020). 
4. Coronavirus (2019).
5. Sejis., et al. “The Myriad Ways in Which COVID-19 Revealed Character”. Organizational Dynamics 14 (2020): 100765. 
6. Ahn., et al. “Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)”. Microbial Biotechnology 30.3 (2020): 313-324. 
7. Bai., et al. “Presumed Asymptomatic Carrier Transmission of COVID-19”. The Journal of the American Medical Association 323.14 (2020): 1406-1407. 
8. Singhal T. “A Review of Coronavirus Disease-2019 (COVID-19)”. Indian Journal of Pediatrics 87.4 (2020): 281-286. 
9. Guo., et al. “Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection”. Journal of the American Heart Association 9.7 (2020): e016219. 
10. Hartman., et al. “COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support”. ASAIO Journal 66.6 (2020): 603-606.
11. Orsucci D., et al. “Neurological features of COVID-19 and their treatment: a review”. Drugs Context 9 (2020). 
12. Quartuccio., et al. “Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome”. Joint Bone Spine 87.3 (2020): 191-193. 
13. Takashi., et al. “Critical illness myopathy as a consequence of Covid-19 infection”. Clinical Neurophysiology 131.8 (2020): 1931-1932. 
14. Kochi AN., et al. “Cardiac and arrhythmic complications in patients with COVID-19”. Journal of Cardiovascular Electrophysiology 31.5 (2020): 1003-1008. 
15. Clerkin., et al. “COVID-19 and Cardiovascular Disease”. Circulation 1410.20 (2020): 1648-1655.
16. Shi., et al. “Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China”. JAMA Cardiology 5.7 (2020): 802-810. 
17. Sifuentes-Rodríguez., et al. “COVID-19: The outbreak caused by a new coronavirus”. Boletín Médico del Hospital Infantil de México 77.2 (2020): 47-53. 
18. Lescure., et al. “Clinical and virological data of the first cases of COVID-19 in Europe: a case series”. The Lancet Infectious Diseases 20.6 (2020): 697-706. 
19. Coronavirus infection in USA (2020).
20. Japan avoided a lockdown by telling everyone to steer clear of the 3 C's. Here's what that means (2020).

Citation

Citation: Sheikh Mohammad Fazle Akbar., et al. “COVID-19: Containment Strategy and Related Complexities in Developing Countries; New Normal and New World Order". Acta Scientific Medical Sciences 4.9 (2020): 80-89.

Copyright

Copyright: © 2020 Sheikh Mohammad Fazle Akbar., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.